{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:24:31Z","timestamp":1783488271323,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s40618-015-0254-2","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T15:57:29Z","timestamp":1425398249000},"page":"769-777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy"],"prefix":"10.1007","volume":"38","author":[{"given":"K. A.","family":"Ponto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Matheis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Kahaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"issue":"8","key":"254_CR1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","volume":"37","author":"L Bartalena","year":"2014","unstructured":"Bartalena L, Fatourechi V (2014) Extrathyroidal manifestations of Graves\u2019 disease: a 2014 update. J Endocrinol Invest 37(8):691\u2013700. doi: 10.1007\/s40618-014-0097-2","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"254_CR2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","volume":"98","author":"ML Tanda","year":"2013","unstructured":"Tanda ML, Piantanida E, Liparulo L, Veronesi G, Lai A, Sassi L, Pariani N, Gallo D, Azzolini C, Ferrario M, Bartalena L (2013) Prevalence and natural history of Graves\u2019 orbitopathy in a large series of patients with newly diagnosed graves\u2019 hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98(4):1443\u20131449. doi: 10.1210\/jc.2012-3873","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"254_CR3","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","volume":"364","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W (2011) Selenium and the course of mild Graves\u2019 orbitopathy. N Engl J Med 364(20):1920\u20131931. doi: 10.1056\/NEJMoa1012985","journal-title":"N Engl J Med"},{"issue":"6","key":"254_CR4","first-page":"444","volume":"36","author":"E Piantanida","year":"2013","unstructured":"Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L (2013) Prevalence and natural history of Graves\u2019 orbitopathy in the XXI century. J Endocrinol Invest 36(6):444\u2013449. doi: 10.3275\/8937","journal-title":"J Endocrinol Invest"},{"key":"254_CR5","first-page":"477","volume":"92","author":"GB Bartley","year":"1994","unstructured":"Bartley GB (1994) The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc 92:477\u2013588","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"254_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1076\/soph.17.1.18.10289","volume":"17","author":"R Ebner","year":"2002","unstructured":"Ebner R (2002) Dysthyroid optic neuropathy (DON). Semin Ophthalmol 17(1):18\u201321. doi: 10.1076\/soph.17.1.18.10289","journal-title":"Semin Ophthalmol"},{"issue":"11","key":"254_CR7","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0161-6420(88)32978-7","volume":"95","author":"JM Neigel","year":"1988","unstructured":"Neigel JM, Rootman J, Belkin RI, Nugent RA, Drance SM, Beattie CW, Spinelli JA (1988) Dysthyroid optic neuropathy. The crowded orbital apex syndrome. Ophthalmology 95(11):1515\u20131521","journal-title":"Ophthalmology"},{"issue":"5","key":"254_CR8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/02713683.2013.848901","volume":"39","author":"Y Du","year":"2014","unstructured":"Du Y, Ye H, Li K, Xiao X, Chen R, He JF, Yang H (2014) Vision-related quality of life tends to be more severely impaired in patients with dysthyroid optic neuropathy. Curr Eye Res 39(5):532\u2013536. doi: 10.3109\/02713683.2013.848901","journal-title":"Curr Eye Res"},{"issue":"3","key":"254_CR9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajo.2011.02.018","volume":"152","author":"KA Ponto","year":"2011","unstructured":"Ponto KA, Hommel G, Pitz S, Elflein H, Pfeiffer N, Kahaly GJ (2011) Quality of life in a german graves orbitopathy population. Am J Ophthalmol 152(3):483\u2013490. doi: 10.1016\/j.ajo.2011.02.018 (e481)","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"254_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1210\/jc.2012-3119","volume":"98","author":"KA Ponto","year":"2013","unstructured":"Ponto KA, Merkesdal S, Hommel G, Pitz S, Pfeiffer N, Kahaly GJ (2013) Public health relevance of Graves\u2019 orbitopathy. J Clin Endocrinol Metab 98(1):145\u2013152. doi: 10.1210\/jc.2012-3119","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"254_CR11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/BF03346732","volume":"34","author":"S Zang","year":"2011","unstructured":"Zang S, Ponto KA, Pitz S, Kahaly GJ (2011) Dose of intravenous steroids and therapy outcome in Graves\u2019 orbitopathy. J Endocrinol Invest 34(11):876\u2013880","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"254_CR12","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","volume":"97","author":"L Bartalena","year":"2012","unstructured":"Bartalena L, Krassas GE, Wiersinga W, Marcocci C, Salvi M, Daumerie C, Bournaud C, Stahl M, Sassi L, Veronesi G, Azzolini C, Boboridis KG, Mourits MP, Soeters MR, Baldeschi L, Nardi M, Curro N, Boschi A, Bernard M, von Arx G (2012) Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves\u2019 orbitopathy. J Clin Endocrinol Metab 97(12):4454\u20134463. doi: 10.1210\/jc.2012-2389","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"254_CR13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","volume":"18","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits MP, Perros P, Boboridis K, Boschi A, Curro N, Daumerie C, Kahaly GJ, Krassas G, Lane CM, Lazarus JH, Marino M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM (2008) Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy. Thyroid Off J Am Thyroid Assoc 18(3):333\u2013346. doi: 10.1089\/thy.2007.0315","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"1","key":"254_CR14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/IOP.0b013e3181df6a87","volume":"27","author":"CH Choe","year":"2011","unstructured":"Choe CH, Cho RI, Elner VM (2011) Comparison of lateral and medial orbital decompression for the treatment of compressive optic neuropathy in thyroid eye disease. Ophthalmic Plast Reconstr Surg 27(1):4\u201311. doi: 10.1097\/IOP.0b013e3181df6a87","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"7","key":"254_CR15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0161-6420(89)32784-9","volume":"96","author":"JR Guy","year":"1989","unstructured":"Guy JR, Fagien S, Donovan JP, Rubin ML (1989) Methylprednisolone pulse therapy in severe dysthyroid optic neuropathy. Ophthalmology 96(7):1048\u20131052 (discussion 1052\u20131043)","journal-title":"Ophthalmology"},{"issue":"9","key":"254_CR16","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(91)32114-6","volume":"98","author":"M Kazim","year":"1991","unstructured":"Kazim M, Trokel S, Moore S (1991) Treatment of acute Graves orbitopathy. Ophthalmology 98(9):1443\u20131448","journal-title":"Ophthalmology"},{"issue":"6","key":"254_CR17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0161-6420(81)34986-0","volume":"88","author":"CR Leone Jr","year":"1981","unstructured":"Leone CR Jr, Bajandas FJ (1981) Inferior orbital decompression for dysthyroid optic neuropathy. Ophthalmology 88(6):525\u2013532","journal-title":"Ophthalmology"},{"issue":"2","key":"254_CR18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0002-9394(14)77786-4","volume":"96","author":"GJ Panzo","year":"1983","unstructured":"Panzo GJ, Tomsak RL (1983) A retrospective review of 26 cases of dysthyroid optic neuropathy. Am J Ophthalmol 96(2):190\u2013194","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"254_CR19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2010-1962","volume":"96","author":"S Zang","year":"2011","unstructured":"Zang S, Ponto KA, Kahaly GJ (2011) Clinical review: Intravenous glucocorticoids for Graves\u2019 orbitopathy: efficacy and morbidity. J Clin Endocrinol Metab 96(2):320\u2013332. doi: 10.1210\/jc.2010-1962","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"254_CR20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12020-012-9607-1","volume":"41","author":"ML Tanda","year":"2012","unstructured":"Tanda ML, Piantanida E, Bartalena L (2012) Treating Graves\u2019 orbitopathy: where are we? Endocrine 41(2):167\u2013168. doi: 10.1007\/s12020-012-9607-1","journal-title":"Endocrine"},{"issue":"4","key":"254_CR21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/IOP.0b013e318179f8a5","volume":"24","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Lai A, Compri E, Marcocci C, Tanda ML (2008) Novel immunomodulating agents for Graves orbitopathy. Ophthalmic Plast Reconstr Surg 24(4):251\u2013256. doi: 10.1097\/IOP.0b013e318179f8a5","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"Suppl 2","key":"254_CR22","first-page":"210","volume":"7","author":"L Bartalena","year":"2010","unstructured":"Bartalena L, Lai A, Sassi L, Lombardi V, Dalle Mule I, Gandolfo M, Liparulo L, Azzolini C, Piantanida E, Tanda ML (2010) Novel treatment modalities for Graves\u2019 orbitopathy. Pediatr Endocrinol Rev PER 7(Suppl 2):210\u2013216","journal-title":"Pediatr Endocrinol Rev PER"},{"issue":"11","key":"254_CR23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/BF03349216","volume":"29","author":"L Bartalena","year":"2006","unstructured":"Bartalena L, Tanda ML (2006) Immunotherapy for Graves\u2019 orbitopathy: easy enthusiasm, but let\u2019s keep trying. J Endocrinol Invest 29(11):1012\u20131016","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"254_CR24","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bjo.2008.149302","volume":"93","author":"MP Mourits","year":"2009","unstructured":"Mourits MP, Bijl H, Altea MA, Baldeschi L, Boboridis K, Curro N, Dickinson AJ, Eckstein A, Freidel M, Guastella C, Kahaly GJ, Kalmann R, Krassas GE, Lane CM, Lareida J, Marcocci C, Marino M, Nardi M, Mohr C, Neoh C, Pinchera A, Orgiazzi J, Pitz S, Saeed P, Salvi M, Sellari-Franceschini S, Stahl M, von Arx G, Wiersinga WM (2009) Outcome of orbital decompression for disfiguring proptosis in patients with Graves\u2019 orbitopathy using various surgical procedures. Br J Ophthalmol 93(11):1518\u20131523. doi: 10.1136\/bjo.2008.149302","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"254_CR25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bjo.2006.110932","volume":"91","author":"CM Dayan","year":"2007","unstructured":"Dayan CM, Dayan MR (2007) Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity? Br J Ophthalmol 91(4):409\u2013410. doi: 10.1136\/bjo.2006.110932","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"254_CR26","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/eye.2008.155","volume":"23","author":"FL Silva da","year":"2009","unstructured":"da Silva FL, de Lourdes Veronese Rodrigues M, Akaishi PM, Cruz AA (2009) Graves\u2019 orbitopathy: frequency of ocular hypertension and glaucoma. Eye (London, England) 23(4):957\u2013959. doi: 10.1038\/eye.2008.155","journal-title":"Eye (London, England)"},{"issue":"4","key":"254_CR27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bjo.2006.094607","volume":"91","author":"D McKeag","year":"2007","unstructured":"McKeag D, Lane C, Lazarus JH, Baldeschi L, Boboridis K, Dickinson AJ, Hullo AI, Kahaly G, Krassas G, Marcocci C, Marino M, Mourits MP, Nardi M, Neoh C, Orgiazzi J, Perros P, Pinchera A, Pitz S, Prummel MF, Sartini MS, Wiersinga WM (2007) Clinical features of dysthyroid optic neuropathy: a European Group on Graves\u2019 Orbitopathy (EUGOGO) survey. Br J Ophthalmol 91(4):455\u2013458. doi: 10.1136\/bjo.2006.094607","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"254_CR28","first-page":"354","volume":"28","author":"A Mensah","year":"2009","unstructured":"Mensah A, Vignal-Clermont C, Mehanna C, Morel X, Galatoire O, Jacomet PV, Morax S (2009) Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss. Orbit (Amsterdam, Netherlands) 28(6):354\u2013362. doi: 10.3109\/01676830903104728","journal-title":"Orbit (Amsterdam, Netherlands)"},{"issue":"6","key":"254_CR29","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","volume":"119","author":"GB Bartley","year":"1995","unstructured":"Bartley GB, Gorman CA (1995) Diagnostic criteria for Graves\u2019 ophthalmopathy. Am J Ophthalmol 119(6):792\u2013795","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"254_CR30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/bjo.2009.173658","volume":"95","author":"A Lipski","year":"2011","unstructured":"Lipski A, Eckstein A, Esser J, Loesch C, Mann K, Mohr C, Jurklies B (2011) Course of pattern-reversed visual evoked cortical potentials in 30 eyes after bony orbital decompression in dysthyroid optic neuropathy. Br J Ophthalmol 95(2):222\u2013226. doi: 10.1136\/bjo.2009.173658","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"254_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10633-012-9325-2","volume":"125","author":"C Perez-Rico","year":"2012","unstructured":"Perez-Rico C, Rodriguez-Gonzalez N, Arevalo-Serrano J, Blanco R (2012) Evaluation of multifocal visual evoked potentials in patients with Graves\u2019 orbitopathy and subclinical optic nerve involvement. Doc Ophthalmol Adv Ophthalmol 125(1):11\u201319. doi: 10.1007\/s10633-012-9325-2","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"issue":"10","key":"254_CR32","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archophthalmol.2011.276","volume":"129","author":"E Weis","year":"2011","unstructured":"Weis E, Heran MK, Jhamb A, Chan AK, Chiu JP, Hurley MC, Rootman J (2011) Clinical and soft-tissue computed tomographic predictors of dysthyroid optic neuropathy: refinement of the constellation of findings at presentation. Arch Ophthalmol 129(10):1332\u20131336. doi: 10.1001\/archophthalmol.2011.276","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"254_CR33","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.ophtha.2012.04.021","volume":"119","author":"E Weis","year":"2012","unstructured":"Weis E, Heran MK, Jhamb A, Chan AK, Chiu JP, Hurley MC, Rootman J (2012) Quantitative computed tomographic predictors of compressive optic neuropathy in patients with thyroid orbitopathy: a volumetric analysis. Ophthalmology 119(10):2174\u20132178. doi: 10.1016\/j.ophtha.2012.04.021","journal-title":"Ophthalmology"},{"issue":"1","key":"254_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.iop.0000192649.23508.f7","volume":"22","author":"LR Dragan","year":"2006","unstructured":"Dragan LR, Seiff SR, Lee DC (2006) Longitudinal correlation of thyroid-stimulating immunoglobulin with clinical activity of disease in thyroid-associated orbitopathy. Ophthalmic Plast Reconstr Surg 22(1):13\u201319","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"Suppl 2","key":"254_CR35","first-page":"198","volume":"7","author":"A Eckstein","year":"2010","unstructured":"Eckstein A, Esser J, Mann K, Schott M (2010) Clinical value of TSH receptor antibodies measurement in patients with Graves\u2019 orbitopathy. Pediatr Endocrinol Rev PER 7(Suppl 2):198\u2013203","journal-title":"Pediatr Endocrinol Rev PER"},{"key":"254_CR36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000417921","volume":"20","author":"G Kahaly","year":"1989","unstructured":"Kahaly G, Grubl M, Moncayo R, Schilling S, Weber P, Beyer J, Krause U (1989) Thyroid-stimulating and eye muscle antibodies in Graves\u2019 disease and Graves\u2019 orbitopathy. Dev Ophthalmol 20:68\u201378","journal-title":"Dev Ophthalmol"},{"issue":"2","key":"254_CR37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02576669","volume":"191","author":"G Kahaly","year":"1991","unstructured":"Kahaly G, Moncayo R, Stover C, Beyer J (1991) Relationship of eye muscle antibodies with HLA phenotypes and thyroid-stimulating immunoglobulins in endocrine orbitopathy. Res Exp Med Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie 191(2):137\u2013144","journal-title":"Res Exp Med Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie"},{"issue":"5","key":"254_CR38","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","volume":"95","author":"SD Lytton","year":"2010","unstructured":"Lytton SD, Ponto KA, Kanitz M, Matheis N, Kohn LD, Kahaly GJ (2010) A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves\u2019 orbitopathy. J Clin Endocrinol Metab 95(5):2123\u20132131. doi: 10.1210\/jc.2009-2470","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"254_CR39","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ophtha.2011.03.030","volume":"118","author":"KA Ponto","year":"2011","unstructured":"Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ (2011) Clinical relevance of thyroid-stimulating immunoglobulins in graves\u2019 ophthalmopathy. Ophthalmology 118(11):2279\u20132285. doi: 10.1016\/j.ophtha.2011.03.030","journal-title":"Ophthalmology"},{"issue":"5","key":"254_CR40","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1210\/jc.2013-4026","volume":"99","author":"T Diana","year":"2014","unstructured":"Diana T, Brown RS, Bossowski A, Segni M, Niedziela M, Konig J, Bossowska A, Ziora K, Hale A, Smith J, Pitz S, Kanitz M, Kahaly GJ (2014) Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves\u2019 disease-a multicenter study. J Clin Endocrinol Metab 99(5):1648\u20131655. doi: 10.1210\/jc.2013-4026","journal-title":"J Clin Endocrinol Metab"},{"key":"254_CR41","author":"T Diana","year":"2014","unstructured":"Diana T, Kanitz M, Lehmann M, Li Y, Olivo PD, Kahaly GJ (2014) Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies. Thyroid Off J Am Thyroid Assoc. doi: 10.1089\/thy.2014.0346","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"8","key":"254_CR42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/thy.2010.0059","volume":"20","author":"K Kamijo","year":"2010","unstructured":"Kamijo K, Murayama H, Uzu T, Togashi K, Kahaly GJ (2010) A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves\u2019 disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells. Thyroid Off J Am Thyroid Assoc 20(8):851\u2013856. doi: 10.1089\/thy.2010.0059","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"12","key":"254_CR43","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/thy.2011.0056","volume":"21","author":"K Kamijo","year":"2011","unstructured":"Kamijo K, Murayama H, Uzu T, Togashi K, Olivo PD, Kahaly GJ (2011) Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves\u2019 disease. Thyroid Off J Am Thyroid Assoc 21(12):1295\u20131299. doi: 10.1089\/thy.2011.0056","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"2","key":"254_CR44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1309\/AJCPZUT7CNUEU7OP","volume":"139","author":"JJ Leschik","year":"2013","unstructured":"Leschik JJ, Diana T, Olivo PD, Konig J, Krahn U, Li Y, Kanitz M, Kahaly GJ (2013) Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins. Am J Clin Pathol 139(2):192\u2013200. doi: 10.1309\/ajcpzut7cnueu7op","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"254_CR45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/eje.1.02230","volume":"155","author":"WM Wiersinga","year":"2006","unstructured":"Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K, Boschi A, Dickinson AJ, Kendall-Taylor P, Krassas GE, Lane CM, Lazarus JH, Marcocci C, Marino M, Nardi M, Neoh C, Orgiazzi J, Pinchera A, Pitz S, Prummel MF, Sartini MS, Stahl M, von Arx G (2006) Clinical assessment of patients with Graves\u2019 orbitopathy: the European Group on Graves\u2019 Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol\/European Fed Endocr Soc 155(3):387\u2013389. doi: 10.1530\/eje.1.02230","journal-title":"Eur J Endocrinol\/European Fed Endocr Soc"},{"issue":"5","key":"254_CR46","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2265.2004.02143.x","volume":"61","author":"AK Eckstein","year":"2004","unstructured":"Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG (2004) Clinical results of anti-inflammatory therapy in Graves\u2019 ophthalmopathy and association with thyroidal autoantibodies. Clin Endocrinol 61(5):612\u2013618. doi: 10.1111\/j.1365-2265.2004.02143.x","journal-title":"Clin Endocrinol"},{"issue":"3","key":"254_CR47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","volume":"52","author":"MN Gerding","year":"2000","unstructured":"Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF (2000) Association of thyrotrophin receptor antibodies with the clinical features of Graves\u2019 ophthalmopathy. Clin Endocrinol 52(3):267\u2013271","journal-title":"Clin Endocrinol"},{"issue":"2","key":"254_CR48","first-page":"114","volume":"44","author":"I Subekti","year":"2012","unstructured":"Subekti I, Boedisantoso A, Moeloek ND, Waspadji S, Mansyur M (2012) Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of Graves ophthalmopathy. Acta medica Indonesiana 44(2):114\u2013121","journal-title":"Acta medica Indonesiana"},{"issue":"3","key":"254_CR49","first-page":"172","volume":"2","author":"Y Bai","year":"1987","unstructured":"Bai Y, Dai WX, Sun ML, Guo ZS, Jin X, Chi ZS (1987) Changes of serum TSI in hyperthyroidism with long-term antithyroid therapy. Proc Chin Acad Med Sci Peking Union Med Coll\u00a0=\u00a0Chung-kuo i hsueh k\u2019o hsueh yuan, Chung-kuo hsieh ho i k\u2019o ta hsueh hsueh pao 2(3):172\u2013174","journal-title":"Proc Chin Acad Med Sci Peking Union Med Coll\u00a0=\u00a0Chung-kuo i hsueh k\u2019o hsueh yuan, Chung-kuo hsieh ho i k\u2019o ta hsueh hsueh pao"},{"issue":"2","key":"254_CR50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000339473","volume":"1","author":"S Kautbally","year":"2012","unstructured":"Kautbally S, Alexopoulou O, Daumerie C, Jamar F, Mourad M, Maiter D (2012) Greater efficacy of total thyroidectomy versus radioiodine therapy on hyperthyroidism and thyroid-stimulating immunoglobulin levels in patients with Graves\u2019 disease previously treated with antithyroid drugs. Eur Thyroid J 1(2):122\u2013128. doi: 10.1159\/000339473","journal-title":"Eur Thyroid J"},{"issue":"5","key":"254_CR51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF03348175","volume":"10","author":"MG Prentice","year":"1987","unstructured":"Prentice MG, Rayman GA, Alaghband-Zadeh J, Wise PH (1987) Thyroid stimulating immunoglobulin bioactivity during carbimazole therapy as measured by the cytochemical bioassay. J Endocrinol Invest 10(5):483\u2013489","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"254_CR52","first-page":"3283","volume":"81","author":"RS Rittmaster","year":"1996","unstructured":"Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE (1996) Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves\u2019 disease. J Clin Endocrinol Metab 81(9):3283\u20133288. doi: 10.1210\/jcem.81.9.8784084","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"254_CR53","first-page":"23","volume":"46","author":"J Szabo","year":"1989","unstructured":"Szabo J, Leovey A, Karanyi Z, Varvolgyi C, Forizs E, Herceg L (1989) Detectability of thyroid anti-microsomal antibodies, changes in thyroid-stimulating immunoglobulins (TSI) and thyrotropin-binding-inhibiting immunoglobulins (TBII) during methimazole treatment of Graves\u2019 disease patients. Acta Med Hung 46(1):23\u201330","journal-title":"Acta Med Hung"},{"issue":"7","key":"254_CR54","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/thy.2010.1640","volume":"20","author":"KA Ponto","year":"2010","unstructured":"Ponto KA, Zang S, Kahaly GJ (2010) The tale of radioiodine and Graves\u2019 orbitopathy. Thyroid Off J Am Thyroid Assoc 20(7):785\u2013793. doi: 10.1089\/thy.2010.1640","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"9","key":"254_CR55","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1210\/jc.2009-0506","volume":"94","author":"G Vannucchi","year":"2009","unstructured":"Vannucchi G, Campi I, Covelli D, Dazzi D, Curro N, Simonetta S, Ratiglia R, Beck-Peccoz P, Salvi M (2009) Graves\u2019 orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis. J Clin Endocrinol Metab 94(9):3381\u20133386. doi: 10.1210\/jc.2009-0506","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"254_CR56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/thy.1995.5.171","volume":"5","author":"VP Michelangeli","year":"1995","unstructured":"Michelangeli VP, Poon C, Topliss DJ, Colman PG (1995) Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves\u2019 disease. Thyroid Off J Am Thyroid Assoc 5(3):171\u2013176","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"1","key":"254_CR57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","volume":"158","author":"P Laurberg","year":"2008","unstructured":"Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Torring O (2008) TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol\/Eur Fed Endocr Soc 158(1):69\u201375. doi: 10.1530\/eje-07-0450","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0254-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0254-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0254-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T15:15:35Z","timestamp":1566400535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0254-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,4]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0254-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,4]]}}}